This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License
Thomas Strüngmann (born 1950) founded generic drug maker Hexal AG ($1.6 billion sales during 2004) in 1986. In 2005, he and his brother Andreas sold Hexal for $6.7B. They earned $8B on their stake in BioNTech SE, the German company developing the Pfizer vaccine. They own approximately 50% of the company as well as significant ownership in 4SC and Immatics. He currently has the largest health-care earned fortune with his brother. The brothers operate out of a family office, Athos Service.
| Property | Value |
|---|---|
| dbo:abstract |
|
| dbo:wikiPageExternalLink | |
| dbo:wikiPageID |
|
| dbo:wikiPageLength |
|
| dbo:wikiPageRevisionID |
|
| dbo:wikiPageWikiLink | |
| dbp:wikiPageUsesTemplate | |
| dcterms:subject | |
| rdf:type |
|
| rdfs:comment |
|
| rdfs:label |
|
| owl:sameAs | |
| prov:wasDerivedFrom | |
| foaf:isPrimaryTopicOf | |
| is dbo:foundedBy of | |
| is dbo:wikiPageRedirects of | |
| is dbo:wikiPageWikiLink of | |
| is foaf:primaryTopic of |